Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy - Takeaways - MDSpire

Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy

  • By

  • Brandon K Hill

  • Andrea M Prinzi

  • J R Kane

  • Amalia K Corby

  • Barbara D Powe

  • October 22, 2025

  • 0 min

Share

  • 1

    In vitro diagnostics (IVDs) are crucial for antimicrobial stewardship and improving patient outcomes in infectious diseases.

  • 2

    Barriers to IVD adoption include high costs, inconsistent reimbursement, and regulatory challenges that limit patient access.

  • 3

    Market access involves regulatory approval, evidence generation, and advocacy to ensure IVDs are affordable and integrated into healthcare.

  • 4

    Healthcare payors significantly influence IVD accessibility through coverage decisions and reimbursement policies.

  • 5

    Clinicians and laboratory professionals must engage in advocacy to promote policies that enhance innovation and access to IVDs.

Original Source(s)

Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy

  • by Brandon K Hill, Andrea M Prinzi, J R Kane, Amalia K Corby, Barbara D Powe

  • October 22, 2025

Related Content

HHS Supports Repatriation of U.S. Citizens to Specialized Care Facilities

Chromoblastomycosis caused by Fonsecaea pedrosoi: a case report and literature review

Key takeaways from WHO briefing on hantavirus cruise ship outbreak